Trial intelligence / Profile preview

CCH Effectiveness and Satisfaction in Cellulite (Real World Study)

NCT04170296Phase 3Completed

Sponsor
Endo International plc
Start
Nov 2019
Primary completion
Oct 2020
Modality
Therapeutic Enzymes
Countries
2
01

Overview

A Phase 3 trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Started Nov 2019; status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

cellulite

Beyond the preview

Go deeper on NCT04170296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04170296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call